Research and regulatory reference
ACE-031
A source-linked reference on the identity and evidence context of ACE-031. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.
Identity
ACE-031 is an activin-receptor-IIB and IgG1-Fc fusion protein.
Sources: Published 2017
A named substance and a finished product are different claims. The name does not verify formulation, concentration, purity or equivalence to material used in a study.
Research context
The trial was stopped after its second dosing regimen because of potential safety concerns including epistaxis and telangiectasias. Its reported trends did not establish a treatment effect.
Sources: Published 2017
The source documents a specific identity or research setting. It does not independently verify a commercial product, establish product equivalence or answer a person-specific health question.
Evidence boundary
This entry reports the limited source context above. It does not make a personal treatment recommendation or infer a result from a different molecule, formulation, model or study population.
The appropriate conclusion is limited to the cited record, not to untested products or uses.
Published sources
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
Published 2017. Current article record; accessed 6 September 2026.
Supports: A randomized, placebo-controlled study in ambulatory boys with Duchenne muscular dystrophy.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.